Now, a pill that comes with a plan.
Get the full picture in OAB care

Toviaz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency

Fesoterodine (INN, brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome. It was approved by the European Medicines Agency in April 2007 and was approved by the US Food and Drug Administration on October 31, 2008.

Fesoterodine is a prodrug. It is broken down into its active metabolite, 5-hydroxymethyl tolterodine, by plasma esterases.

More on Wikipedia

Brand name: Toviaz
Generic name/category: Fesoterodine, Muscarinic antagonists, Prodrugs
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: Overactive bladder OAB
Target: Healthcare Professionals (HCP)
Tagline: Get the full picture in OAB care
Medium: Print ad
Size/duration: single-page
Publication/Aired: Urology Times – September 2009

To see all of this brand's ads on AdPharm, click here
1 views
Sep 07, 2009

Visit AdPharm.net for more pharmaceutical ads

3,6 mmol/L à 100 km/h
Le verra-t-elle avant qu’il ne soit trop tard?

3.6 mmol/L at 100 km per hour. Will she see it before it’s too late?

L’hypoglycémie peut rendre potentiellement dangeureuse une situation ordinaire. Pour vos patients utilisant de l’insuline, c’est alors que l’exactitude est importante…

Hypoglycemia may potentially make ordinary situations dangerous. For patients using insulin, then accuracy is important …

Brand name: OneTouch
Generic name/category: Blood Glucose Meter
Company: Lifescan, a Johnson & Johnson Company
Country/Market: Canada, North America
Indication(s)/use: Diabetes
Target: Healthcare Professionals (HCP)
Tagline: Ça change tout – It changes everything
Publication: Le Médecin Du Québec July 2009

To see all of this brand’s ads on AdPharm, click here